Synergy Pharmaceuticals, Inc. (SGYP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: November 21, 2014
Pages: 43
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S955B132BE9EN
Leaflet:

Download PDF Leaflet

Synergy Pharmaceuticals, Inc. (SGYP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Synergy Pharmaceuticals, Inc. (Synergy Pharma) is a bio pharmaceutical company. The company develops therapies for gastrointestinal diseases and disorders. Its products include plecanatide and SP-333. Synergy Pharma’s plecanatide is a drug candidate used to treat chronic idiopathic constipation and irritable bowel syndrome with constipation. The company’s SP-333 is a GC-C agonist, which is used in the treatment of opioid-induced constipation and mild-to-moderate ulcerative colitis. It develops product based on the natural human hormone, uroguanylin. The company conducts research and development of uroguanylin analogs. It serves the needs of people suffering from gastrointestinal illnesses. Synergy Pharma is headquartered in New York, the US.

Synergy Pharmaceuticals, Inc. (SGYP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details
Asset Purchase
Synergy Pharma Acquires FV-100 From Bristol-Myers Squibb
Licensing Agreements
Synergy Pharma Enters Into Agreement With Ironwood Pharma For Plecanatide
Callisto Pharma Amends Its Licensing Agreement with Genzyme
Equity Offering
ContraVir Pharma Raises USD9 Million in Private Placement of Preferred Shares
Synergy Pharma Announces Public Offering Of Shares For Up To US$50 Million
ContraVir Pharma Completes Private Placement Of Securities For US$3 Million
Synergy Pharma Completes Public Offering Of Shares For US$90 Million
Synergy Pharma Completes Exercise Of Underwriters' Option For Public Offering Of Shares For US$51.75 Million
Synergy Pharma Completes Exercise Of Over-Allotment Option For Public Offering Of Units For US$17.25 Million
Synergy Pharma Files Registration Statement For Public Offering Of Units For US$0.5 Million
Synergy Pharma Completes Private Placement Of Common Stock For US$5.7 Million
Synergy Pharma Files Registration Statement For Public Offering Of US$2.5 Million
Synergy Pharma Completes Private Placement Of US$0.4 Million
Synergy Pharma Completes Private Placement Of US$3 Million
Synergy Pharma Completes Private Placement Of US$8.6 Million
Synergy Pharma Completes Private Placement Of US$7 Million
Callisto Pharma Completes Private Placement Of US$11.24 Million
Synergy Pharma Completes Private Placement For US$3 Million
Debt Offering
Synergy Pharma Raises USD200 Million in Private Placement of 7.5% Notes Due 2019
Acquisition
Synergy Pharma Completes Acquisition Of Callisto Pharma
Pawfect Foods Acquires Synergy Pharma
Synergy Pharmaceuticals, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Key Facts, 2013
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Deals By Therapy Area, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Synergy Pharma Acquires FV-100 From Bristol-Myers Squibb
Synergy Pharma Enters Into Agreement With Ironwood Pharma For Plecanatide
Callisto Pharma Amends Its Licensing Agreement with Genzyme
ContraVir Pharma Raises USD9 Million in Private Placement of Preferred Shares
Synergy Pharma Announces Public Offering Of Shares For Up To US$50 Million
ContraVir Pharma Completes Private Placement Of Securities For US$3 Million
Synergy Pharma Completes Public Offering Of Shares For US$90 Million
Synergy Pharma Completes Exercise Of Underwriters' Option For Public Offering Of Shares For US$51.75 Million
Synergy Pharma Completes Exercise Of Over-Allotment Option For Public Offering Of Units For US$17.25 Million
Synergy Pharma Files Registration Statement For Public Offering Of Units For US$0.5 Million
Synergy Pharma Completes Private Placement Of Common Stock For US$5.7 Million
Synergy Pharma Files Registration Statement For Public Offering Of US$2.5 Million
Synergy Pharma Completes Private Placement Of US$0.4 Million
Synergy Pharma Completes Private Placement Of US$3 Million
Synergy Pharma Completes Private Placement Of US$8.6 Million
Synergy Pharma Completes Private Placement Of US$7 Million
Callisto Pharma Completes Private Placement Of US$11.24 Million
Synergy Pharma Completes Private Placement For US$3 Million
Synergy Pharma Raises USD200 Million in Private Placement of 7.5% Notes Due 2019
Synergy Pharma Completes Acquisition Of Callisto Pharma
Pawfect Foods Acquires Synergy Pharma
Synergy Pharmaceuticals, Inc., Key Competitors
Synergy Pharmaceuticals, Inc., Key Employees
Synergy Pharmaceuticals, Inc., Subsidiaries

LIST OF FIGURES

Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Synergy Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Skip to top


Ask Your Question

Synergy Pharmaceuticals, Inc. (SGYP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: